Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 05/31/2020 (updated monthly) $1,306.2 (M)
Net Assets - Class A As of 05/31/2020 (updated monthly) $1,061.5 (M)
P/E Ratio (12-mo Forward)As of 05/31/2020 (updated monthly) 18.52
P/B RatioAs of 05/31/2020 (updated monthly) 6.40

Positions As of 05/31/2020

Portfolio Details

Asset AllocationAs of 06/30/2020

[name] [value]
Equity 95.65%
Cash & Cash Equivalents 4.35%

Geographic BreakdownAs of 06/30/2020

No chart available for this data.
[name] [value]
United States 82.65%
Cash & Cash Equivalents 4.35%
United Kingdom 4.07%
Netherlands 3.13%
Denmark 2.30%
Canada 2.08%
Switzerland 0.90%
Germany 0.54%

sector breakdownAs of 05/31/2020

[name] [value]
Biotechnology 78.50%
Pharmaceuticals 10.24%
Cash & Cash Equivalents 6.37%
Life Sciences Tools & Services 4.89%

TOP TEN HOLDINGSAs of 06/30/2020

46.29%
Other
0% 100%
[holdings-table-heading]
VERTEX PHARMACEUTICALS INC 7.17%
REGENERON PHARMACEUTICALS INC 6.71%
AMGEN INC 5.51%
ILLUMINA INC 4.78%
GILEAD SCIENCES INC 4.53%
NOVAVAX INC 4.34%
GW PHARMACEUTICALS PLC 3.80%
BIOGEN INC 3.71%
REATA PHARMACEUTICALS INC 2.88%
IOVANCE BIOTHERAPEUTICS INC 2.86%